Skip to main content
Charles Quinn, MD, Pediatric Hematology & Oncology, Cincinnati, OH

CharlesQuinnMDMS

Pediatric Hematology & Oncology Cincinnati, OH

Pediatric Anemia and Red Blood Cell Hematology

Medical Director, Erythrocyte Diagnostic Laboratory; Medical Director, Pediatric Sickle Cell Program

Dr. Quinn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Quinn's full profile

Already have an account?

  • Office

    3333 Burnet Ave
    # ML7015
    Cincinnati, OH 45229
    Phone+1 513-636-4266
    Fax+1 513-636-3549

Education & Training

  • UT Southwestern Medical Center
    UT Southwestern Medical CenterMS, Clinical Sciences, 2005 - 2008
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 1998 - 2001
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterChief Residency, Pediatrics, 1998
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 1994
  • Texas Christian University
    Texas Christian UniversityBS, Biology, Magna cum laude, 1986 - 1990

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2010 - 2026
  • IN State Medical License
    IN State Medical License 2021 - 2025
  • KY State Medical License
    KY State Medical License 2022 - 2025
  • TX State Medical License
    TX State Medical License 1996 - 2024
  • FL State Medical License
    FL State Medical License 2015 - 2017
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Top Doctor U.S. News and World Report, 2011
  • Dean’s Scholar in Clinical Science 2005
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • L-glutamine for Sickle Cell Anemia: More Questions Than Answers  
    Charles Quinn, MD, Blood
  • Yet another mechanism of action for hydroxyurea in sickle cell disease?  
    Quinn CT, The Hematologist: ASH News and Reports, 7/1/2014
  • Lessons from the liver: rebalanced hemostasis in immune thrombocytopenia (ITP)  
    Quinn CT, The Hematologist: ASH News and Reports, 5/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • An Immersive Virtual Reality Curriculum for Pediatric Providers on Shared Decision Making for Hydroxyurea
    Charles T. Quinn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Feasibility of Electronic Monitoring of Daily Oral Medications in Adolescents with Sickle Cell Disease
    Charles T. Quinn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Progression of Albuminuria in Sickle Cell Anemia: A Multicenter, Longitudinal Study
    Charles T. Quinn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Evaluation of Phenotype-Genotype Correlation in Two Common PIEZO1 Mutations p.R2456H and p.L2495_E2495dup 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • “Sickle cell disease: a tale of survival”. 
    Memphis, TN - 4/1/2014
  • “Hemolytic Anemia" 
    New Orleans, LA - 12/1/2013
  • Join now to see all

Other

  • Sickle cell disease in children and adolescents: diagnosis, guidelines for comprehensive care, and care paths and protocols for management of acute and chronic complic... 
    Lane PA, Buchanan GR, Hutter JJ, Austin RF, Britton HA, Rogers ZR, Eckman JR, DeBaun MR, Wang WC, Mathew P, Iden S, Recht M, Cohen JD, Frugé E, Embry L, Hsu L, Mueller...
    http://scinfo.org/care-paths-and-protocols-children-adolescents/
    11/1/2001

Press Mentions

  • Does Our Healthcare System Abandon Adult Sickle Cell Patients?
    Does Our Healthcare System Abandon Adult Sickle Cell Patients?March 22nd, 2016

Grant Support

  • A Controlled Clinical Trial of Regadenoson in Sickle Cell AnemiaNational Institutes of Health (NHLBI)2012–Present
  • Hydroxyurea to prevent CNS complications of sickle cell disease in children.National Institutes of Health2011–2013